Literature DB >> 6493974

Haemophilus pleuropneumoniae serotypes--cross protection experiments.

R Nielsen.   

Abstract

Pigs vaccinated with a killed 6-hour culture of Haemophilus pleuropneumoniae serotype 2 with Freund's incomplete adjuvant were not protected against challenge with serotypes 1, 5, 6 or 8. Equivalent results were obtained when pigs were vaccinated with serotypes 4 or 5 and challenged with serotype 2. In earlier studies of immunity induced by intranasal immunization with live H. pleuropneumoniae organisms, it was clearly shown that intranasal inoculation with one serotype of H. pleuropneumoniae would induce a strong immunity to both homologous and heterologous serotypes (Nielsen 1979). The present study has shown that cross immunity is not obtained with parenteral immunization. The results strongly suggest that the immune response of the pig to parenteral vaccination is different from the response seen after natural infection, and indicate that an important part of the defence mechanism against H. pleuropneumoniae infection is a local immune-barrier which is effective in preventing the bacterium from penetrating the mucosa. In earlier vaccination experiments 90 per cent of vaccinates were protected against homologous challenge (Nielsen 1976). In the present work a vaccine containing serotypes 1 through 6 was fully protective against serotypes 2 and 3 and also against serotype 8, which shares antigenic determinants with serotypes 3 and 6. These results indicate that the protection obtained by parenteral immunization is serotype-specific. Vaccines must therefore contain the serotypes existing in the swine population.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6493974

Source DB:  PubMed          Journal:  Nord Vet Med        ISSN: 0029-1579


  32 in total

1.  Association of the RTX proteins of Actinobacillus pleuropneumoniae with hemolytic, CAMP, and neutrophil-cytotoxic activities.

Authors:  J Devenish; J E Brown; S Rosendal
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

3.  Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.

Authors:  Alexander Maas; Ilse D Jacobsen; Jochen Meens; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker.

Authors:  Jinlin Liu; Yan Chen; Fangyan Yuan; Linlin Hu; Weicheng Bei; Huanchun Chen
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

5.  Analysis of major antigens of Haemophilus (Actinobacillus) pleuropneumoniae and related organisms.

Authors:  J I MacInnes; S Rosendal
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Effect of iron restriction on the outer membrane proteins of Actinobacillus (Haemophilus) pleuropneumoniae.

Authors:  H G Deneer; A A Potter
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

7.  Characterization of the antigenic lipopolysaccharide O chain and the capsular polysaccharide produced by Actinobacillus pleuropneumoniae serotype 13.

Authors:  Leann L MacLean; Malcolm B Perry; Evguenii Vinogradov
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection.

Authors:  V J Rapp; R F Ross
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Prevalence of seroreactors to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae in swine herds.

Authors:  J Devenish; S Rosendal; J T Bossé; B N Wilkie; R Johnson
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

10.  Characterization of Actinobacillus pleuropneumoniae riboflavin biosynthesis genes.

Authors:  T E Fuller; M H Mulks
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.